Intravenous immunoglobulin (IVIg) products are not interchangeable—there are important product differences, and this makes matching the right product with the right patient extremely important. There are multiple IVIg formulations on the market, each with different specific physical and chemical properties that do impact and influence patient safety and satisfaction, resource utilization, and overall costs of care. This report reviews the experience of the continued use of IVIg product Privigen by several institutions after switching from another IVIg product, and provides an overview of the physical and chemical characteristics of Privigen.

Download to read this article in PDF document:
Pharmacy Experience With IVIg: Perspectives on the Commitment to Use Privigen

This article is in PDF format and it requires Abobe Reader. If you do not have Adobe Reader installed on your computer then please download and install from the link below.
Download Adobe Reader